Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
E3 ubiquitin-protein ligase TRIM63 (commonly called MuRF1) is an enzyme predominantly expressed in striated muscle and is a key regulator of muscle protein catabolism[1][2][3]. It belongs to the RING-type E3 ubiquitin ligase subgroup within the tripartite motif (TRIM) protein family, distinguished by their zinc finger domains and coiled-coil regions that mediate protein-protein interactions[3]. TRIM63 is localized at the sarcomere Z-line and M-line where it interacts with proteins such as titin and myosin[1][2][3]. Its primary function is tagging specific muscle proteins, especially myosin, for proteasomal degradation—a process upregulated during periods of muscle atrophy, disuse, glucocorticoid treatment, or cachexia[1][2][4]. Genetically, variants in TRIM63 are associated with certain forms of hypertrophic cardiomyopathy[1]. As a central mediator of muscle protein breakdown, TRIM63 is a validated target for skeletal muscle wasting and related conditions, although no drugs are yet approved to target it directly. Upregulation of TRIM63/MuRF1 is routinely used as a molecular biomarker for muscle atrophy[1].
Induction of ubiquitination and degradation of muscle proteins (e.g., myosin heavy chain, creatine kinase, actin) Regulation of sarcomere stability and muscle cell structure
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on E3 ubiquitin-protein ligase TRIM63 (TRIM63).